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Pancreatic cancer is currently one of the deadliest forms of cancer.  This is due to high local recurrence 
and invasiveness.  Recurrence is thought to be due in part to the resistance of pancreatic cancer cells.  
Treatment for pancreatic cancer includes chemotherapy, radiation therapy and surgery.  Currently, about 
94% of all patients diagnosed with pancreatic cancer die within 5 years of diagnosis.  Thus, the focus of 
this research is to develop a better therapeutic approach to therapy in order to improve the killing of 
cancer cells and prevent recurrence.  We investigated two drugs, Dichloroacetate (DCA) and 
Dimethylaminoparthenolide (DMAPT, a derivative of Parthenolide).  Both DCA and DMAPT were 
studied for their ability to radiosensitize and help increase radiation induced cell killing in drug treated 
cancer cells.   The experiment involved pancreatic cancer cells (MIA PACA2) being exposed to DMAPT, 
DCA, and dual treatment, with or without radiation.  The cells were then tested for survival rates and 
doubling times.  The hypothesis is that DCA and DMAPT will enhance radiation-induced cell killing of 
MIA PACA2 cells.  The results show that DMAPT and DCA are in fact toxic to the pancreatic cancer cell 
lines. The dual treatment suppressed cell growth, and increased doubling time of MIA PACA2 cells. Dual 
treatment also decreased the survival rate of the MIA PACA2 cells (depending on radiation dosage).  The 
data shows that dual treatment of DCA and DMAPT radiation are beneficial in slowing down the spread 
of pancreatic cancer.  Future research will study the mechanisms of radiation sensitization and could help 
to develop a new technique to treat pancreatic cancer. 
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